Influence of additive bright light treatment considering chronotype on sleep and circadian rhythms, state of health, pain experience and cognition in elderly depressed patients

Not Applicable

• Conditions: F32; F33; Depressive episode; Recurrent depressive disorder

• Registration Number: DRKS00010397
• Lead Sponsor: Vitos - Klinikum Gießen und MarburgÄrztlicher Direktor

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-07-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

F32- Major depressive Episode
F33- Recurrent depressive disorder

Exclusion Criteria

(1) Important somatic comorbidity
(2) Endocrine diseases (especially of the adrenal Cortex, thyroid hyper- or hypofunction),
(3) Recent (within the last four weeks) disruptions of sleep-wake rhythmicity due to exogenous conditions such as shift work or travel across time zones with jet lag.
(4) Marked suicidal ideation or severe agitation
(5) No capacity of discernment
(6) Diseases of the the eye
(7) Mental disorders of the ICD-10 groups F0, F1 (except F17), F5-F7.
(8) Neurological diseases with severe somatosensory deficits,
(9) Organic sleep disoders, (
10) Current or recent (3 months at maximum) treatment with steroids (except contraceptives), (11) Pregnancy,

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mean improvement in the Hamilton Scale for Depression scores from T0 (Baseline) to T2 (after 2 weeks))